0.35
+0.0031(+0.89%)
Currency In USD
| Previous Close | 0.35 |
| Open | 0.35 |
| Day High | 0.36 |
| Day Low | 0.34 |
| 52-Week High | 3.45 |
| 52-Week Low | 0.24 |
| Volume | 740,526 |
| Average Volume | 398,472 |
| Market Cap | 24.88M |
| PE | -0.95 |
| EPS | -0.37 |
| Moving Average 50 Days | 0.42 |
| Moving Average 200 Days | 0.88 |
| Change | 0 |
If you invested $1000 in Ovid Therapeutics Inc. (OVID) since IPO date, it would be worth $28.57 as of April 29, 2025 at a share price of $0.35. Whereas If you bought $1000 worth of Ovid Therapeutics Inc. (OVID) shares 5 years ago, it would be worth $91.62 as of April 29, 2025 at a share price of $0.35.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ovid Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Apr 02, 2025 12:00 PM GMT
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that Meg Alexander, President and Ch
Ovid Therapeutics Appoints Pioneering Industry Leader Dr. Stelios Papadopoulos to Board of Directors
GlobeNewswire Inc.
Mar 03, 2025 1:00 PM GMT
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant unmet need, today announced the appointment of St
Ovid Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference
GlobeNewswire Inc.
Feb 27, 2025 1:00 PM GMT
NEW YORK, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines for brain conditions with significant unmet need, today announced that Meg Alexander, President and Chi